Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > AGM was horrible

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on May 15, 2023 5:13pm

123 Views

Post# 35449100

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:AGM was horrible

Unfortunately when you make 2 million dollars a year working for a company whos worth sub 100million you are going to be held accountable for a lot of the failures regardless of how much of a part you played in it. You seem to defend him to a fault which is admirable but not very realistic

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December